NRG4 and Insulin resistance: Since LD is also characterized by insulin resistance, chronic low-grade inflammation, and MASLD (17), reduced NRG4 levels in our cohort likely reflect a metabolically adverse phenotype and may be attributable to the loss of functional AT, the primary site of NRG4 production (11).